ImmunityBio, Inc. (IBRX)
USD 2.84
(-4.38%)
USD 2.84
(-4.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 836.95 Million USD | 189.38% |
| 2022 | 289.22 Million USD | -15.78% |
| 2021 | 343.41 Million USD | 26.94% |
| 2020 | 270.53 Million USD | 48.95% |
| 2019 | 181.62 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 5.2 Million USD | 81.73% |
| 2016 | 2.86 Million USD | 15.96% |
| 2015 | 2.46 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 850.5 Million USD | 24.79% |
| 2024 Q2 | 956.26 Million USD | 12.43% |
| 2023 Q3 | 712.9 Million USD | 141.94% |
| 2023 FY | 836.95 Million USD | 189.38% |
| 2023 Q1 | 291.92 Million USD | 0.94% |
| 2023 Q2 | 294.66 Million USD | 0.94% |
| 2023 Q4 | 836.95 Million USD | 17.4% |
| 2022 Q2 | 363.18 Million USD | 5.07% |
| 2022 Q4 | 289.22 Million USD | -59.3% |
| 2022 Q3 | 710.61 Million USD | 95.66% |
| 2022 FY | 289.22 Million USD | -15.78% |
| 2022 Q1 | 345.67 Million USD | 0.66% |
| 2021 Q4 | 343.41 Million USD | 1.64% |
| 2021 FY | 343.41 Million USD | 26.94% |
| 2021 Q2 | 329.36 Million USD | 4.95% |
| 2021 Q3 | 337.88 Million USD | 2.58% |
| 2021 Q1 | 313.84 Million USD | 16.01% |
| 2020 Q2 | 9.46 Million USD | -7.05% |
| 2020 FY | 270.53 Million USD | 48.95% |
| 2020 Q4 | 270.53 Million USD | 4.59% |
| 2020 Q3 | 258.66 Million USD | 2633.72% |
| 2020 Q1 | 10.18 Million USD | -94.39% |
| 2019 Q4 | 181.62 Million USD | 1448.08% |
| 2019 Q3 | 11.73 Million USD | -2.21% |
| 2019 Q2 | 11.99 Million USD | -5.92% |
| 2019 Q1 | 12.75 Million USD | 0.0% |
| 2019 FY | 181.62 Million USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | 3.19 Million USD | 11.64% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q4 | 5.2 Million USD | 0.0% |
| 2017 FY | 5.2 Million USD | 81.73% |
| 2016 Q4 | 2.86 Million USD | 144.62% |
| 2016 Q2 | 2.13 Million USD | 1357.06% |
| 2016 Q3 | 1.17 Million USD | -45.25% |
| 2016 FY | 2.86 Million USD | 15.96% |
| 2016 Q1 | -170 Thousand USD | -106.89% |
| 2015 FY | 2.46 Million USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 2.46 Million USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -1075.131% |
| Alkermes plc | 287.73 Million USD | -190.881% |
| Agenus Inc. | 137.32 Million USD | -509.472% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 64.279% |
| Aptorum Group Limited | 3.05 Million USD | -27264.787% |
| Ardelyx, Inc. | 51.54 Million USD | -1523.668% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -700.084% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1988.204% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -731.977% |
| ChromaDex Corporation | 2.57 Million USD | -32402.99% |
| Chimerix, Inc. | 125 Thousand USD | -669461.6% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -25742.771% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -3130.477% |
| CRISPR Therapeutics AG | 223 Million USD | -275.303% |
| Precision BioSciences, Inc. | 7.72 Million USD | -10737.136% |
| Dyadic International, Inc. | 88.87 Thousand USD | -941671.126% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -3804227.273% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1275.299% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1360886.08% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -21919.258% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -928567.17% |
| Incyte Corporation | 29.16 Million USD | -2770.009% |
| IO Biotech, Inc. | 1.83 Million USD | -45411.256% |
| Jaguar Health, Inc. | 30.99 Million USD | -2600.455% |
| Novavax, Inc. | 168.01 Million USD | -398.138% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -3534.971% |
| Opthea Limited | 200.53 Million USD | -317.358% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -14443.041% |
| ContextLogic Inc. | 6 Million USD | -13849.2% |
| MiMedx Group, Inc. | 48.09 Million USD | -1640.061% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -4064.147% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -2185666.89% |
| NextCure, Inc. | 5.94 Million USD | -13968.785% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -577108.276% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -3685.229% |
| PDS Biotechnology Corporation | 19.5 Million USD | -4190.701% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -624.759% |
| Pharming Group N.V. | 166.1 Million USD | -403.869% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -13370.98% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -2397.246% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -69299.005% |
| Acelyrin, Inc. | 1.19 Million USD | -69996.482% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -181846.087% |
| Summit Therapeutics Inc. | 103.29 Million USD | -710.293% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -22106.209% |
| Senti Biosciences, Inc. | 33.53 Million USD | -2395.533% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -17435.135% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -2322.016% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -1287.497% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -53209.045% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -3194.568% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -702.155% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -114237.705% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -7378.795% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -505.154% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -6127.785% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -5479.68% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -338.351% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1489.411% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1275.299% |
| Precigen, Inc. | 5.89 Million USD | -14097.659% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1893.312% |
| AlloVir, Inc. | 16.64 Million USD | -4927.343% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -1172.795% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -759.647% |
| ImmuCell Corporation | 10.54 Million USD | -7840.347% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -74295.733% |
| Onconetix, Inc. | 118.85 Thousand USD | -704067.193% |
| PureTech Health plc | 18.25 Million USD | -4486.038% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -845306.061% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2677.158% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -3123.509% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1852.12% |
| Innoviva, Inc. | 446.23 Million USD | -87.559% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -100374.43% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -1251997.421% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -304.387% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -1075.56% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -26153.199% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -80531.214% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -3648.777% |
| Aptose Biosciences Inc. | 621 Thousand USD | -134674.879% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -82689.974% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1693.802% |
| Kura Oncology, Inc. | 9.33 Million USD | -8868.624% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -3034.652% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -606386.957% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -8817.975% |
| Autolus Therapeutics plc | 47.91 Million USD | -1646.78% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -16959.764% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -12257.183% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -540.557% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -10226.366% |
| IGM Biosciences, Inc. | 34.67 Million USD | -2313.913% |
| INmune Bio, Inc. | 397 Thousand USD | -210719.144% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -381.691% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -20543.767% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -569452.702% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1581.572% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1433.722% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1731.685% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -76.808% |
| Verastem, Inc. | 40.08 Million USD | -1987.891% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -18912.994% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -8224.567% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -12656.47% |
| Histogen Inc. | 4.38 Million USD | -18991.058% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -94792.517% |
| Organovo Holdings, Inc. | 888 Thousand USD | -94151.351% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -2689.84% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -19855.937% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -4329.489% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -1005.617% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -898843.117% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -3130.602% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -313365.169% |
| Amarin Corporation plc | 8.73 Million USD | -9479.398% |
| Mesoblast Limited | 100.48 Million USD | -732.929% |
| Turnstone Biologics Corp. | 1.18 Million USD | -70291.253% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -968.508% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -767745.872% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -920.561% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -340.631% |
| Better Therapeutics, Inc. | 10.34 Million USD | -7988.056% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -3519.252% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -799.629% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -64679.567% |
| Gritstone bio, Inc. | 40.14 Million USD | -1984.874% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -46038.479% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -444.915% |
| Insmed Incorporated | 1.19 Billion USD | 29.865% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -13080.346% |
| OmniAb, Inc. | 22.07 Million USD | -3691.402% |
| Alector, Inc. | 30.45 Million USD | -2648.069% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -724.226% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -10300.795% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -96.194% |
| Aura Biosciences, Inc. | 16.87 Million USD | -4861.186% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1371.073% |
| Immunic, Inc. | 639 Thousand USD | -130878.404% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -2706.774% |
| Veracyte, Inc. | 7.52 Million USD | -11022.286% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -29.787% |
| FibroGen, Inc. | 89.69 Million USD | -833.088% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -19197.948% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -639463.513% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 83.615% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2261932.432% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -42170.303% |
| TG Therapeutics, Inc. | 100.11 Million USD | -735.966% |
| Galecto, Inc. | 66 Thousand USD | -1268009.091% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -615305.882% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 48.729% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -13814.414% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -15407.727% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -46038.479% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -3802.42% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -2189.569% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -161786.267% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1750.19% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -2637.463% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1768.113% |
| Vaxxinity, Inc. | 13.26 Million USD | -6210.903% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -3.166% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -186281.563% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -9422.722% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 69.035% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -264758.228% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -18674.159% |
| Ainos, Inc. | 5.92 Million USD | -14033.988% |
| Pluri Inc. | 29.05 Million USD | -2780.777% |
| Prothena Corporation plc | 10.72 Million USD | -7706.66% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -4116.17% |
| Celularity Inc. | 26.17 Million USD | -3097.28% |
| Rallybio Corporation | 173 Thousand USD | -483687.283% |
| Cue Biopharma, Inc. | 4.2 Million USD | -19817.944% |
| MeiraGTx Holdings plc | 72.11 Million USD | -1060.515% |
| Omeros Corporation | 329.7 Million USD | -153.849% |
| Humacyte, Inc. | 38.6 Million USD | -2068.269% |
| Immunocore Holdings plc | 82.64 Million USD | -912.72% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -51787.911% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -23298.155% |
| Blueprint Medicines Corporation | 610.96 Million USD | -36.989% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -57304.115% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -779.253% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1619.152% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -820.729% |
| Pulmatrix, Inc. | 8.32 Million USD | -9951.063% |
| Elicio Therapeutics, Inc. | 6 Million USD | -13832.945% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -6365.446% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -765.093% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -178354.584% |
| Cytokinetics, Incorporated | 607.37 Million USD | -37.799% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -9528.992% |
| Nutriband Inc. | 79.82 Thousand USD | -1048370.423% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -18565.299% |
| Vor Biopharma Inc. | 31.83 Million USD | -2529.444% |
| Roivant Sciences Ltd. | 477.85 Million USD | -75.147% |
| Evogene Ltd. | 10.65 Million USD | -7756.491% |
| ProKidney Corp. | 3.61 Million USD | -23084.266% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -110170.356% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -3179084.077% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 51.78% |
| CorMedix Inc. | 517.01 Thousand USD | -161782.196% |
| BioLineRx Ltd. | 6.62 Million USD | -12527.52% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -2171.98% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -1066.63% |
| Atai Life Sciences N.V. | 15.21 Million USD | -5402.281% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -99254.574% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -328116.471% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1839.634% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -203706.555% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -61036.012% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -126118.257% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -370.013% |
| Biomea Fusion, Inc. | 7.83 Million USD | -10589.042% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -194.481% |
| Mereo BioPharma Group plc | 5.3 Million USD | -15691.547% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -38828.0% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -142238.776% |
| Absci Corporation | 4.66 Million USD | -17860.343% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -7163.947% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -3587.826% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -8265.337% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -7174.681% |
| Allakos Inc. | 38.21 Million USD | -2090.114% |
| Imunon, Inc. | 1.13 Million USD | -73362.402% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -9599.293% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -100013.876% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -8369420.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -847.357% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -17673.455% |
| XOMA Corporation | 118.51 Million USD | -606.181% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -8212.166% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -2157.213% |
| aTyr Pharma, Inc. | 13.76 Million USD | -5979.407% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -10495.67% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -3252.636% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -4042.301% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -5579580.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -300756.249% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -5690.109% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 44.175% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -614524.044% |
| UroGen Pharma Ltd. | 98.55 Million USD | -749.258% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -461.283% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -4289.532% |
| Entera Bio Ltd. | 256 Thousand USD | -326834.375% |
| GH Research PLC | 631 Thousand USD | -132538.986% |
| Lisata Therapeutics, Inc. | 137.00 USD | -610913768.613% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -130266.355% |
| Xencor, Inc. | 14.64 Million USD | -5616.104% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -556935.893% |
| Replimune Group, Inc. | 71.99 Million USD | -1062.595% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -557868.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -11846.218% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -614524.044% |
| Portage Biotech Inc. | 7000.00 USD | -11956357.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -126118.257% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -58469.069% |
| OncoCyte Corporation | 2.2 Million USD | -37874.229% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -1250855.833% |
| Purple Biotech Ltd. | 163 Thousand USD | -513367.485% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -32915.858% |
| scPharmaceuticals Inc. | 38.81 Million USD | -2056.481% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -3215.449% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -1146409.589% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -45067.404% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -3076.53% |
| Curis, Inc. | 1.48 Million USD | -56108.999% |
| Daré Bioscience, Inc. | 3.91 Million USD | -21285.317% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -119856.143% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -13949100.0% |
| BeiGene, Ltd. | 197.61 Million USD | -323.52% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -91721.393% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -938.724% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1512.966% |
| bluebird bio, Inc. | 224.41 Million USD | -272.942% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -41.116% |
| DBV Technologies S.A. | 4.52 Million USD | -18392.09% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -62359.104% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -8491.172% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -22117.998% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -121.848% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1851.984% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -48645.02% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -90088.793% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -4691.618% |
| MacroGenics, Inc. | 30.19 Million USD | -2671.731% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -4627.741% |
| Prime Medicine, Inc. | 4.35 Million USD | -19109.364% |
| Aditxt, Inc. | 1.04 Million USD | -80241.427% |
| Adagene Inc. | 13.54 Million USD | -6081.314% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -5992.684% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -61.354% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -4796.461% |
| SciSparc Ltd. | 24 Thousand USD | -3487200.0% |
| Vericel Corporation | 81.85 Million USD | -922.469% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -920.464% |
| Generation Bio Co. | 89.77 Million USD | -832.288% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -3672.603% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -314.745% |
| Invivyd, Inc. | 722 Thousand USD | -115821.33% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1625.603% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -28626072.731% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -21781.098% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -3638821.739% |
| 2seventy bio, Inc. | 244.01 Million USD | -242.995% |
| ADMA Biologics, Inc. | 130.59 Million USD | -540.881% |
| Clene Inc. | 7.15 Million USD | -11602.349% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -24689.33% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -238.003% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -75917.439% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -318296.135% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -334.509% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -2846.703% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -8582.975% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -649.467% |
| Evaxion Biotech A/S | 8.48 Million USD | -9759.545% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -1017.053% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -1193.289% |
| Trevena, Inc. | 35.23 Million USD | -2275.478% |
| Surrozen, Inc. | 882 Thousand USD | -94792.517% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -13364.479% |
| Cingulate Inc. | 135.09 Thousand USD | -619410.137% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -3455.597% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1650.946% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -464873.333% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -3197.813% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -4699.862% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -89317.949% |
| Statera Biopharma, Inc. | 11.43 Million USD | -7221.684% |
| Korro Bio, Inc. | 31.21 Million USD | -2581.164% |
| Kineta, Inc. | 150 Thousand USD | -557868.0% |
| BioVie Inc. | 349.89 Thousand USD | -239101.587% |
| Codexis, Inc. | 12.24 Million USD | -6736.168% |
| Celularity Inc. | 26.17 Million USD | -3097.28% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1659.966% |
| Celcuity Inc. | 37.03 Million USD | -2159.87% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -474510.565% |
| Cibus, Inc. | 17.67 Million USD | -4635.498% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -24669.222% |
| Kodiak Sciences Inc. | 100 Million USD | -736.952% |
| Annexon, Inc. | 29.19 Million USD | -2767.256% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -1195.05% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -74494.652% |
| Avalo Therapeutics, Inc. | 2 Million USD | -41747.6% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 40.234% |
| Eyenovia, Inc. | 8.95 Million USD | -9243.87% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -1174.695% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -10179.44% |
| Arcellx, Inc. | 50.84 Million USD | -1546.215% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -57304.115% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -3840.823% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -79231.943% |
| Moolec Science SA | 99.04 Thousand USD | -844913.428% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2930.129% |
| Geron Corporation | 35.05 Million USD | -2287.812% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -141516.244% |
| Royalty Pharma plc | 6.13 Billion USD | 86.358% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -50871.498% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -2636633.665% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -3515.656% |
| Humacyte, Inc. | 38.6 Million USD | -2068.269% |
| Structure Therapeutics Inc. | 4.01 Million USD | -20756.018% |
| 89bio, Inc. | 24.79 Million USD | -3275.487% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -6631.157% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -44752.733% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -81000.0% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -741.09% |
| Notable Labs, Ltd. | 1.52 Million USD | -54746.134% |
| Liquidia Corporation | 2.36 Million USD | -35304.061% |
| Mustang Bio, Inc. | 1.97 Million USD | -42213.043% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -5992.684% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -11937.279% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -263922.713% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1578.032% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -8614.619% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -1277903.94% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -615305.882% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -13261.303% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -643709.231% |
| PepGen Inc. | 17.1 Million USD | -4794.456% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -176472.152% |
| United Therapeutics Corporation | 300 Million USD | -178.984% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -3395.894% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -20005.255% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -144701.384% |
| XOMA Corporation | 118.51 Million USD | -606.181% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -2261932.432% |
| Bionomics Limited | 117.62 Million USD | -611.524% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -89605.466% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -14818.93% |
| uniQure N.V. | 130.06 Million USD | -543.487% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1328.49% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -121904.665% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -19197.948% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -60329.747% |
| Altimmune, Inc. | 175 Thousand USD | -478158.286% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -115.788% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -14818.93% |
| Compugen Ltd. | 719 Thousand USD | -116305.007% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -16420.963% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -889.831% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -8328.52% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -13020.426% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -815.602% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -8328.52% |
| Instil Bio, Inc. | 81.42 Million USD | -927.856% |
| argenx SE | 15.35 Million USD | -5351.036% |
| Immunome, Inc. | 1.34 Million USD | -62359.104% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -156047.761% |
| Verona Pharma plc | 48.37 Million USD | -1630.169% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -8981.51% |
| Shattuck Labs, Inc. | 3.4 Million USD | -24472.871% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -984549.412% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -498085.714% |
| Moolec Science SA | 99.04 Thousand USD | -844913.428% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -7486.539% |
| AnaptysBio, Inc. | 16.03 Million USD | -5118.881% |
| Design Therapeutics, Inc. | 2.33 Million USD | -35759.126% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -3091592.217% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -13849.2% |
| Achilles Therapeutics plc | 1.07 Million USD | -77683.643% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -8981.51% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -4198094.222% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -4898.987% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -1048370.423% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -11217591.998% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -6437992.308% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -144.378% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -3318.363% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -33378.214% |
| Palisade Bio, Inc. | 90 Thousand USD | -929846.667% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -431318.557% |
| Beam Therapeutics Inc. | 159.91 Million USD | -423.386% |
| Neurogene Inc. | 13.37 Million USD | -6158.521% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -173.138% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -3086.81% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1398970.576% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -83595.2% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1966.14% |
| Athira Pharma, Inc. | 1.21 Million USD | -68671.734% |
| Vaccinex, Inc. | 26 Thousand USD | -3218946.154% |
| HCW Biologics Inc. | 6.3 Million USD | -13175.853% |
| XOMA Corporation | 118.51 Million USD | -606.181% |
| Nektar Therapeutics | 112.62 Million USD | -643.132% |
| Arvinas, Inc. | 800 Thousand USD | -104519.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -5690.109% |
| Merus N.V. | 10.48 Million USD | -7880.092% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -5522.788% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -6132.422% |
| Rezolute, Inc. | 1.66 Million USD | -50318.795% |
| Clene Inc. | 7.15 Million USD | -11602.349% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -1140969.968% |
| BeyondSpring Inc. | 3.36 Million USD | -24779.667% |
| Synlogic, Inc. | 12.49 Million USD | -6600.44% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -2462.935% |
| Krystal Biotech, Inc. | 6.62 Million USD | -12542.779% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -389.678% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -13858.506% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1766702.474% |
| MannKind Corporation | 252.15 Million USD | -231.925% |
| Ikena Oncology, Inc. | 7.18 Million USD | -11556.713% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -420478.894% |
| Gossamer Bio, Inc. | 197.4 Million USD | -323.977% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -160852.308% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -197.5% |
| Mural Oncology plc | 8.91 Million USD | -9292.347% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -1813.646% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -58183.565% |
| Champions Oncology, Inc. | 6.09 Million USD | -13636.288% |
| REGENXBIO Inc. | 82.22 Million USD | -917.917% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -169322.453% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -18775.778% |
| Vaxart, Inc. | 2.62 Million USD | -31808.197% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -308020.943% |
| Cellectis S.A. | 36.24 Million USD | -2209.406% |
| Longeveron Inc. | 1.44 Million USD | -57700.552% |
| Repare Therapeutics Inc. | 1.01 Million USD | -82766.535% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 26.098% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1769.49% |
| Revolution Medicines, Inc. | 80.57 Million USD | -938.724% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -25989.526% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -472754.237% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -680348.78% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -15.489% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1760.679% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -6593.34% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -619410.137% |
| Passage Bio, Inc. | 22.92 Million USD | -3551.464% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -13759.116% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -129258.887% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -4050.518% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -170706.531% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -205308.669% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -70350.505% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -179503.433% |
| OmniAb, Inc. | 22.07 Million USD | -3691.402% |
| Anew Medical, Inc. | 1.54 Million USD | -54247.532% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -2731.368% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -9165.493% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -2592.03% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -20543.767% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1523.353% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -13045.155% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -5823.646% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -124446.429% |
| Alumis Inc. Common Stock | 30.86 Million USD | -2612.093% |
| Equillium, Inc. | 384 Thousand USD | -217856.25% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -13489.089% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -454.093% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -1612.294% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -695609.132% |
| Dominari Holdings Inc. | 3.02 Million USD | -27540.423% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -4232702.306% |
| vTv Therapeutics Inc. | 169 Thousand USD | -495137.87% |
| Bio-Techne Corporation | 319 Million USD | -162.367% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1368.646% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -368.707% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -5332.284% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -6658.879% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -17311.109% |
| Nkarta, Inc. | 82.27 Million USD | -917.323% |
| BioCardia, Inc. | 982 Thousand USD | -85129.328% |
| Iterum Therapeutics plc | 18.95 Million USD | -4315.235% |